JG

James Douglas Griffin

DI Dana-Farber Cancer Institute: 11 patents #63 of 1,343Top 5%
NA Novartis Ag: 4 patents #1,111 of 5,128Top 25%
University of Michigan: 1 patents #1,906 of 4,352Top 45%
📍 Needham, MA: #128 of 796 inventorsTop 20%
🗺 Massachusetts: #10,511 of 88,656 inventorsTop 15%
Overall (All Time): #412,598 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
11136409 Compositions and methods for identification, assessment, prevention, and treatment of AML using USP10 biomarkers and modulators Sara Jean Buhrlage, Ellen Weisberg 2021-10-05
10155987 Methods of predicting resistance to JAK inhibitor therapy Martin Sattler, Anagha Deshpande 2018-12-18
9700565 Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias Doriano Fabbro, Scott A. Armstrong 2017-07-11
8492429 Combination of IAP inhibitors and FLT3 inhibitors Leigh Zawel 2013-07-23
8445479 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity Paul W. Manley 2013-05-21
8222244 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity Paul W. Manley 2012-07-17
7973031 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity Paul W. Manley 2011-07-05
5219997 Monoclonal antibody which inhibits the adhesion functions of the .beta. integrin, CR3 Stuart F. Schlossman 1993-06-15
5019648 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein Stuart F. Schlossman 1991-05-28
4935234 Method of reducing tissue damage at an inflammatory site using a monoclonal antibody Robert F. Todd, III, Paul J. Simpson, Benedict R. Lucchesi, Stuart F. Scholossman 1990-06-19
4931395 Monoclonal antibody specific to neutrophils 1990-06-05
4840793 Method of reducing tissue damage at an inflammatory site using a monoclonal antibody Robert F. Todd, III, Benedict R. Lucchesi, Paul J. Simpson, Stuart F. Schlossman 1989-06-20